This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Dec 21;44(12):2326-8.

doi: 10.1016/j.jacc.2004.09.032.

Genetic screening and risk assessment in hypertrophic cardiomyopathy

Calum A MacRae, Patrick T Ellinor

PMID: 15607393
DOI: 10.1016/j.jacc.2004.09.032

Free article

Editorial

Genetic screening and risk assessment in hypertrophic cardiomyopathy

Calum A MacRae et al. J Am Coll Cardiol. 2004.

Free article

. 2004 Dec 21;44(12):2326-8.

doi: 10.1016/j.jacc.2004.09.032.

Authors

Calum A MacRae, Patrick T Ellinor

PMID: 15607393
DOI: 10.1016/j.jacc.2004.09.032

No abstract available

PubMed Disclaimer

Comment on

Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klausen IC, Elliott PM, McKenna WJ. Mogensen J, et al. J Am Coll Cardiol. 2004 Dec 21;44(12):2315-25. doi: 10.1016/j.jacc.2004.05.088. J Am Coll Cardiol. 2004. PMID: 15607392

Similar articles

The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
Christiaans I, Wilde AA. Christiaans I, et al. Am J Cardiol. 2011 Jun 15;107(12):1871. doi: 10.1016/j.amjcard.2011.02.357. Am J Cardiol. 2011. PMID: 21640227 No abstract available.
Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D. Ly HQ, et al. Can J Cardiol. 2005 Apr;21(5):441-8. Can J Cardiol. 2005. PMID: 15861263 Review.
State-of-the-art management of hypertrophic cardiomyopathy in children.
Berger S, Dhala A, Dearani JA. Berger S, et al. Cardiol Young. 2009 Nov;19 Suppl 2:66-73. doi: 10.1017/S1047951109991648. Cardiol Young. 2009. PMID: 19857352 Review. No abstract available.
Sudden cardiac death risk in hypertrophic cardiomyopathy.
Ommen SR, Gersh BJ. Ommen SR, et al. Eur Heart J. 2009 Nov;30(21):2558-9. doi: 10.1093/eurheartj/ehp307. Epub 2009 Aug 25. Eur Heart J. 2009. PMID: 19706724 No abstract available.
Risk assessment in hypertrophic cardiomyopathy.
Saumarez RC. Saumarez RC. Heart. 2009 Mar;95(5):421; author reply 421. Heart. 2009. PMID: 19218265 No abstract available.

See all similar articles

Cited by

Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs.
Kithcart A, MacRae CA. Kithcart A, et al. JACC Basic Transl Sci. 2017 Feb 27;2(1):1-12. doi: 10.1016/j.jacbts.2017.01.004. eCollection 2017 Feb. JACC Basic Transl Sci. 2017. PMID: 30167552 Free PMC article. Review.
Genetic etiology and evaluation of sudden cardiac death.
Dolmatova E, Mahida S, Ellinor PT, Lubitz SA. Dolmatova E, et al. Curr Cardiol Rep. 2013 Aug;15(8):389. doi: 10.1007/s11886-013-0389-8. Curr Cardiol Rep. 2013. PMID: 23812838 Review.
Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery.
Macrae CA. Macrae CA. Expert Opin Drug Discov. 2010 Jul;5(7):619-632. doi: 10.1517/17460441.2010.492826. Expert Opin Drug Discov. 2010. PMID: 20835353 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information